Published in Antimicrob Agents Chemother on November 21, 2011
Comparative genome-wide analysis reveals that Burkholderia contaminans MS14 possesses multiple antimicrobial biosynthesis genes but not major genetic loci required for pathogenesis. Microbiologyopen (2016) 0.88
A Burkholderia cepacia complex non-ribosomal peptide-synthesized toxin is hemolytic and required for full virulence. Virulence (2012) 0.85
The first reported case of Burkholderia contaminans in patients with cystic fibrosis in Ireland: from the Sargasso Sea to Irish Children. BMC Pulm Med (2016) 0.82
The Burkholderia contaminans MS14 ocfC gene encodes a xylosyltransferase for production of the antifungal occidiofungin. Appl Environ Microbiol (2013) 0.77
The presence of two cyclase thioesterases expands the conformational freedom of the cyclic Peptide occidiofungin. J Nat Prod (2013) 0.75
Draft Genome Sequence of Burkholderia pyrrocinia Lyc2, a Biological Control Strain That Can Suppress Multiple Plant Microbial Pathogens. Genome Announc (2014) 0.75
Echinocandin antifungal drugs. Lancet (2003) 5.92
Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance. Clin Microbiol Rev (1999) 5.51
The Saccharomyces cerevisiae FKS1 (ETG1) gene encodes an integral membrane protein which is a subunit of 1,3-beta-D-glucan synthase. Proc Natl Acad Sci U S A (1994) 3.90
Effect of Candida glabrata FKS1 and FKS2 mutations on echinocandin sensitivity and kinetics of 1,3-beta-D-glucan synthase: implication for the existing susceptibility breakpoint. Antimicrob Agents Chemother (2009) 3.13
In vitro pharmacodynamic properties of MK-0991 determined by time-kill methods. Diagn Microbiol Infect Dis (1999) 2.57
Postantifungal effects of echinocandin, azole, and polyene antifungal agents against Candida albicans and Cryptococcus neoformans. Antimicrob Agents Chemother (2000) 2.50
Influence of test conditions on antifungal time-kill curve results: proposal for standardized methods. Antimicrob Agents Chemother (1998) 2.43
In vivo efficacy of anidulafungin and caspofungin against Candida glabrata and association with in vitro potency in the presence of sera. Antimicrob Agents Chemother (2007) 1.47
Characterizing the effects of caspofungin on Candida albicans, Candida parapsilosis, and Candida glabrata isolates by simultaneous time-kill and postantifungal-effect experiments. Antimicrob Agents Chemother (2006) 1.34
Mechanisms of resistance to antifungal agents: yeasts and filamentous fungi. Rev Iberoam Micol (2008) 1.26
Fluconazole for the management of invasive candidiasis: where do we stand after 15 years? J Antimicrob Chemother (2006) 1.26
FsFKS1, the 1,3-beta-glucan synthase from the caspofungin-resistant fungus Fusarium solani. Eukaryot Cell (2006) 1.08
In vitro pharmacodynamics of anidulafungin and caspofungin against Candida glabrata isolates, including strains with decreased caspofungin susceptibility. Antimicrob Agents Chemother (2006) 1.06
Photoaffinity analog of the semisynthetic echinocandin LY303366: identification of echinocandin targets in Candida albicans. Antimicrob Agents Chemother (1998) 1.05
Occidiofungin, a unique antifungal glycopeptide produced by a strain of Burkholderia contaminans. Biochemistry (2009) 1.01
Isolation and partial characterization of antibiotics produced by Paenibacillus elgii B69. FEMS Microbiol Lett (2010) 0.99
Biosynthesis of an antifungal oligopeptide in Burkholderia contaminans strain MS14. Biochem Biophys Res Commun (2009) 0.93
Genetic and biochemical map for the biosynthesis of occidiofungin, an antifungal produced by Burkholderia contaminans strain MS14. Appl Environ Microbiol (2011) 0.93
AmbR1 is a key transcriptional regulator for production of antifungal activity of Burkholderia contaminans strain MS14. FEMS Microbiol Lett (2009) 0.91
Cepacidine A, a novel antifungal antibiotic produced by Pseudomonas cepacia. II. Physico-chemical properties and structure elucidation. J Antibiot (Tokyo) (1994) 0.89
Burkholdines 1097 and 1229, potent antifungal peptides from Burkholderia ambifaria 2.2N. Org Lett (2010) 0.87
Role of micafungin in the antifungal armamentarium. Curr Med Chem (2007) 0.85
Cepacidine A, a novel antifungal antibiotic produced by Pseudomonas cepacia. I. Taxonomy, production, isolation and biological activity. J Antibiot (Tokyo) (1994) 0.84
Anidulafungin: review of a new echinocandin antifungal agent. Expert Rev Anti Infect Ther (2004) 0.83
Micafungin: a sulfated echinocandin. J Antibiot (Tokyo) (2009) 0.81
Regional-dependent intestinal absorption and meal composition effects on systemic availability of LY303366, a lipopeptide antifungal agent, in dogs. J Pharm Sci (2001) 0.80
FR220897 and FR220899, novel antifungal lipopeptides from Coleophoma empetri no. 14573. J Antibiot (Tokyo) (2006) 0.79
Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature. Nat Prod Rep (2013) 5.38
In vitro and in vivo studies on thermistor-based intracoronary temperature measurements: effect of pressure and flow. Catheter Cardiovasc Interv (2009) 2.04
Bacterial diversity analysis of Huanglongbing pathogen-infected citrus, using PhyloChip arrays and 16S rRNA gene clone library sequencing. Appl Environ Microbiol (2009) 1.41
Coronary thermodilution to assess flow reserve: validation in humans. Circulation (2002) 1.20
Occidiofungin, a unique antifungal glycopeptide produced by a strain of Burkholderia contaminans. Biochemistry (2009) 1.01
Biosynthesis of an antifungal oligopeptide in Burkholderia contaminans strain MS14. Biochem Biophys Res Commun (2009) 0.93
Genetic and biochemical map for the biosynthesis of occidiofungin, an antifungal produced by Burkholderia contaminans strain MS14. Appl Environ Microbiol (2011) 0.93
Site-directed mutations in the lanthipeptide mutacin 1140. Appl Environ Microbiol (2013) 0.92
AmbR1 is a key transcriptional regulator for production of antifungal activity of Burkholderia contaminans strain MS14. FEMS Microbiol Lett (2009) 0.91
Characterization of the transcriptional activators SalA and SyrF, Which are required for syringomycin and syringopeptin production by Pseudomonas syringae pv. syringae. J Bacteriol (2006) 0.89
IA3, an aspartic proteinase inhibitor from Saccharomyces cerevisiae, is intrinsically unstructured in solution. Biochemistry (2004) 0.88
Oxidation of lanthionines renders the lantibiotic nisin inactive. Appl Environ Microbiol (2008) 0.84
Rapid method for extracting the antibiotic mutacin 1140 from complex fermentation medium yeast extract. Can J Microbiol (2009) 0.84
The expression of genes encoding lipodepsipeptide phytotoxins by Pseudomonas syringae pv. syringae is coordinated in response to plant signal molecules. Mol Plant Microbe Interact (2006) 0.83
Identification of the syr-syp box in the promoter regions of genes dedicated to syringomycin and syringopeptin production by Pseudomonas syringae pv. syringae B301D. J Bacteriol (2006) 0.82
Commercial development and application of type A lantibiotics. Recent Pat Antiinfect Drug Discov (2011) 0.80
The leader peptide of mutacin 1140 has distinct structural components compared to related class I lantibiotics. Microbiologyopen (2014) 0.79
Nonclinical toxicological evaluation of occidiofungin, a unique glycolipopeptide antifungal. Int J Toxicol (2012) 0.79
Draft Genome Sequence of Pseudomonas chlororaphis YL-1, a Biocontrol Strain Suppressing Plant Microbial Pathogens. Genome Announc (2014) 0.78
Multipronged approach for engineering novel peptide analogues of existing lantibiotics. Expert Opin Drug Discov (2015) 0.78
Mutational analysis and homology modelling of SyrC, the aminoacyltransferase in the biosynthesis of syringomycin. Biochem Biophys Res Commun (2007) 0.77
The Burkholderia contaminans MS14 ocfC gene encodes a xylosyltransferase for production of the antifungal occidiofungin. Appl Environ Microbiol (2013) 0.77
The antifungal occidiofungin triggers an apoptotic mechanism of cell death in yeast. J Nat Prod (2013) 0.76
The pqqC gene is essential for antifungal activity of Pseudomonas kilonensis JX22 against Fusarium oxysporum f. sp. lycopersici. FEMS Microbiol Lett (2014) 0.76
The presence of two cyclase thioesterases expands the conformational freedom of the cyclic Peptide occidiofungin. J Nat Prod (2013) 0.75
Medical claims and current applications of the potent echinocandin antifungals. Recent Pat Antiinfect Drug Discov (2010) 0.75
SecG is required for antibiotic activities of Pseudomonas sp. YL23 against Erwinia amylovora and Dickeya chrysanthemi. J Basic Microbiol (2015) 0.75